Park Jung S DDS ,
-
Non-Surgical Alternatives to Plastic Surgery: Do They Really Work?
Non-surgical aesthetic treatments—such as neuromodulators, dermal fillers, laser and light therapies, radiofrequency or ultrasound skin tightening, chemical peels, and body-contouring options like cryolipolysis—can meaningfully improve mild to moderate concerns with less downtime and lower upfront risk than surgery. They work best for fine lines, early laxity, uneven tone/texture, and small pockets of fat, but they cannot replicate the dramatic or long-lasting changes of surgical procedures and often require maintenance sessions. Safety and results depend heavily on proper patient selection, realistic expectations, and a qualified provider using evidence-based, FDA-cleared devices and products. For patients and caregivers, the key value lies in customizable, stepwise plans that fit personal goals, budget, and recovery needs, with clear discussion of benefits, limits, side effects, and total long-term cost. Ultimately, “worth it” is individual—seek a consultation that includes photos, expected longevity of results, and a timeline comparing non-surgical care to surgical options.
-
Aurora Bay Area Prices – GUIDEWIRE 1 is $320
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002906, regarding GUIDEWIRE 1, which is classified under revenue code 272 and associated with CPT code C1769, the designated fee stands at $320. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Are Children’s Vaccines Still Covered? What the 2026 Schedule Fight Means for Parents
A plain-language guide to what changed in 2026, which vaccine schedule many pediatric practices and states are using, and how coverage works now for private insurance and VFC.
-
CMS proposes faster prior authorization decisions for drugs
CMS has proposed new rules that could make drug prior authorization decisions faster and more transparent for many patients and clinicians. The proposal would set 24-hour deadlines for urgent requests and 72-hour deadlines for standard requests, but it is not final yet.
